CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

undervalued biotech, page-4

  1. fluffynymph
    56,627 Posts.
    lightbulb Created with Sketch. 267
    clock Created with Sketch.
    10/07/07
    16:10
    Post #: 2607753
    Source: ABN AMRO Morgans

    Chemgenex (CXS) Achieved: Results from Quinamed Phase 2 trial; 3QCY07: Interim results of Ceflatonin registration directed clinical trial.
    CXS Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
NEWS New gold-copper assays boost confidence in major porphyry target—discover the potential
right-arrow Created with Sketch.
NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS Major acquisition of high-grade antimony deposit, find out who's securing global assets
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.